Company news

Share this article:
Medical device company Uroplasty announced plans to double its US sales force by the end of its fiscal 2009, which began April 1, 2008. “We have successfully launched our second generation Urgent PC neuromodulation system in the US and in fiscal 2008 built a domestic sales force that has generated significant year-to-date sales growth,” said CEO David Kaysen, in a statement.  The sales team is expected to increase from 18 to 36 by March 31, 2009.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Researchers hit links for charity

The PMR Charities Golf Classic teed up more than $20,000 for St. Jude Children's Research Hospital.

FDA to review Neupogen biosimilar

Novartis subsidiary Sandoz announced Thursday that the FDA has agreed to review its filgrastim biosimilar which is already approved in 40 countries.

FDA approves a new painkiller

Targiniq ER combines the prescription opioid oxycodone and naloxone, which is often used to treat overdoses.